A human pluripotent stem cell triculture platform to elucidate microglial regulation of retinal ganglion cells in neuroinflammation
Open accessThe DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index; 2 of the 65 sources its claims cite were checked for support.
Abstract
Optic neuropathies, including glaucoma, are characterized by the progressive degeneration of retinal ganglion cells (RGCs), ultimately leading to irreversible vision loss. Increasing evidence implicates microglia, the resident immune cells of the central nervous system, as key modulators of RGC health and disease progression. However, the precise mechanisms by which microglia influence RGCs remain poorly understood, particularly in the human context. In this study, we established human pluripotent stem cell-derived coculture systems incorporating microglia, astrocytes, and RGCs to explore how microglia shape RGC growth and maturation under physiological conditions. We first examined the impact of homeostatic microglia on RGCs in both coculture and triculture systems, revealing distinct influences of cell types in coculture compared to when they were grown individually. We then modeled inflammatory states by activating microglia with lipopolysaccharide and evaluated their effects on RGCs both directly and in the context of astrocyte coculture. This stepwise, reductionist approach enabled us to dissect the cellular interactions driving RGC vulnerability in inflammatory conditions relevant to optic neuropathies. Our findings provide insight into the complex neuroimmune landscape that underlies RGC degeneration and identify key pathways that may serve as therapeutic targets across a range of optic nerve diseases.
Overview
CoChat Summary
TL;DR
The authors developed hPSC-derived co- and tri-culture systems of microglia, astrocytes, and retinal ganglion cells (RGCs) to model homeostatic and LPS-induced neuroinflammatory interactions. They report that homeostatic microglia enhance RGC maturation, whereas LPS-activated microglia, especially with astrocytes, drive RGC degeneration and pro-inflammatory transcriptional programs.
Key findings
- hPSC-derived microglia co-cultured with RGCs for 3 weeks enhanced RGC morphology—increased soma size, neurite length, and neurite complexity by Sholl analysis—and increased electrophysiological activity by multielectrode array, including mean firing rate and burst frequency, compared with RGCs alone.
- In tri-culture (RGC:microglia:astrocyte 5:1:2) for 1 week, all three cell types showed enhanced morphological maturation versus monoculture; scRNA-seq showed tri-culture RGCs upregulated maturation markers (NEFL, RBPMS, SYN1) and axonal growth/excitability genes, while monoculture RGCs expressed higher developmental genes (VSX2, RAX, ATOH7, SIX6).
- LPS (150 ng/ml, 24 h) activated hPSC-derived microglia, increasing MHC-II/CD74 expression, pro-inflammatory cytokine secretion by MSD V-Plex, and phagocytosis of pHrodo Zymosan-Red at all time points; LPS-activated microglia co-cultured with RGCs for 3 weeks reduced RGC soma size, neurite length, primary neurite number, mean firing rate, and burst frequency/percentage.
- In tri-culture with LPS every 48 h, RGC viability decreased at 1 week and further at 3 weeks, with retracted RGC morphology, reactive astrocytes (increased soma area, reduced branch length), and amoeboid microglia; scRNA-seq showed pro-inflammatory upregulation of RGC neuroinflammation/stress genes (CCL2, ADAM17, SPP1, SQSTM1, CTSD, TIGAR), astrocyte inflammatory/complement genes (CXCL10, CCL3, CXCL1, C1QA/C1QC/C1R), and microglial inflammatory/complement genes, while control microglia expressed homeostatic markers (P2RY12, CX3CR1, INPP5D, CSF1R).
Methods
- hPSC lines WTC-11 and H7 were differentiated into microglia-like cells via hematopoietic progenitors, astrocytes via a neural progenitor protocol, and RGCs from Brn3b-tdTomato-Thy1.2 retinal organoids followed by MACS sorting against Thy1.2.
- Co-cultures used RGC:microglia at 5:1; tri-cultures used RGC:microglia:astrocyte at 5:1:2. Microglia were activated with LPS (150 ng/ml) for 24 h or every 48 h for sustained activation; assays included immunocytochemistry, qRT-PCR, MSD V-Plex proinflammatory panel, pHrodo Zymosan phagocytosis, multielectrode array, and scRNA-seq (10x Chromium/NovaSeq 6000; GEO accession GSE308054).
- Statistics used Student’s t-test or one-way ANOVA with Tukey post-hoc at p < 0.05; scRNA-seq differential expression used the Wilcoxon rank-sum test with p < 0.05.
Limitations
- Stated in the paper: the 2D co-/tri-culture systems do not fully recapitulate the in vivo retinal microenvironment; future 3D microphysiological systems such as retinal organoids and microfluidic platforms are needed.
- Stated in the paper: cellular ratios were selected from prior studies to support survival and reproducible crosstalk, not to replicate in vivo abundance; a single native ratio is difficult to define because glial abundance differs between retina and optic nerve head/optic nerve. Current limitations also included loss of RGCs prior to functional maturation in organoids and reduced control over cell number, timing, and cell-type ratios, necessitating 2D platforms.
- Stated in the paper: LPS was used as a standard pro-inflammatory stimulus, but comprehensive comparison of activation paradigms was beyond scope; TNFα activation was only proof-of-concept. The OPTN(E50K) mutation did not produce significantly greater degeneration than control RGCs in the presence of LPS-stimulated microglia, likely because the robust neurotoxic effect of activated microglia masked additional vulnerability. Evident from the text: the study relies on in vitro morphological, functional, and scRNA-seq readouts without in vivo validation or direct mechanistic perturbation of the identified pathways.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 1 Not valid · 31 Not checked · 67 Own results and interpretations
None of the sources cited for this claim have been checked yet.
In the paper
“tri-culture RGCs upregulated maturation markers (NEFL, RBPMS, SYN1) (27, 28)”
§ A human pluripotent stem cell tri-culture platform to elucidate microglial regulation of retinal ganglion cells in neuroinflammation > RESULTS > Single Cell RNA-seq profiling of RGCs, microglia, and astrocytes to identify transcriptional correlates of cellular maturation in tri-culture
What the sources say
- Could not verifycites [27] Kwong JM, Caprioli J, Piri N, RNA binding protein with multiple splicing: a new marker for retinal ganglion cells. Invest Ophthalmol Vis Sci 51, 1052– 1058 (2010). 19737887 PMC3979483 sourceExperimental — accuracy not yet measured
Our copy of Kwong et al. (2010) is an in vivo rat study: RBPMS mRNA/protein was localized by in situ hybridization and immunohistochemistry in retinas with optic nerve transection and FluoroGold retrograde labeling (Abstract; Retrograde Labeling; RGC Quantification in Wholemounted Retina), and it reports RBPMS co-localizing with Thy-1, NF-H and III beta-tubulin (Discussion, Table 2). It contains no cell-culture or tri-culture experiment and no report of upregulation of NEFL, RBPMS or SYN1 (synapsin I) as maturation markers; searched for 'retinal ganglion cell culture in vitro maturation neurofilament light SYN1 synapsin' and 'NEFL neurofilament light chain synapsin gene expression upregulation'. Nothing in our copy contradicts the tri-culture finding, so the claim is simply not addressed by this source. (LLM, conf=0.70)
- Not checked yetcites [28] Agarwal D, Human retinal ganglion cell neurons generated by synchronous BMP inhibition and transcription factor mediated reprogramming. NPJ Regen Med 8, 55 (2023). 37773257 PMC10541876 source
Checked before — its earlier verdict is held back until a new check runs.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
None of the sources cited for this claim have been checked yet.
In the paper
“treatment with LPS for 24 hours, at which point they exhibited increased MHC-II expression as a characteristic of an activated microglial state (Figure 4A–D) (31, 32).”
§ A human pluripotent stem cell tri-culture platform to elucidate microglial regulation of retinal ganglion cells in neuroinflammation > RESULTS > Stimulating a pro-inflammatory signature in microglia to explore neuroinflammatory phenotypes
What the sources say
- Not checked yetcites [31] Hayes GM, Woodroofe MN, Cuzner ML, Microglia are the major cell type expressing MHC class II in human white matter. J Neurol Sci 80, 25– 37 (1987). 3302117 source
Checked before — its earlier verdict is held back until a new check runs.
- Could not verifycites [32] Harms AS, MHCII is required for alpha-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration. J Neurosci 33, 9592– 9600 (2013). 23739956 PMC3903980 sourceExperimental — accuracy not yet measured
Our copy of Harms et al. (2013) contains no LPS experiment and no human pluripotent stem cell–derived microglia: all in vitro work uses primary murine microglia from postnatal P0–P2 pups stimulated with 500 nM aggregated α-syn (Midbrain fractionation protocol), and the MHCII upregulation reported is after AAV2-SYN α-syn overexpression in mouse SNpc ('striking increase in staining for MHCII in cells with the morphological characteristics of activated microglia', α-Syn overexpression increases MHCII expression in vivo). Searched: LPS/lipopolysaccharide, 24-hour stimulation, hPSC/iPSC-derived microglia — no passage addresses the claim. The paper does state generally that MHCII 'are expressed on activated microglia' (α-Syn overexpression increases MHCII expression in vivo), but that is background, not the LPS/24 h/hPSC result attributed here. (LLM, conf=0.70)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not checked yet
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Successful differentiation was then further confirmed via immunocytochemistry, which demonstrated robust expression of microglia-specific markers IBA1, P2RY12, and TREM2 in nearly all differentiated cells (Figure 1C–E).”
§ A human pluripotent stem cell tri-culture platform to elucidate microglial regulation of retinal ganglion cells in neuroinflammation > RESULTS > Microglia Enhance Retinal Ganglion Cell Morphological Complexity and Functional Maturation
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“we observed that LPS-activated pro-inflammatory microglia reduced the mean firing rate of RGCs compared to controls (Figure 5H–J).”
§ A human pluripotent stem cell tri-culture platform to elucidate microglial regulation of retinal ganglion cells in neuroinflammation > RESULTS > Pro-inflammatory microglia promote RGC neurodegenerative phenotypes
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“when co-cultured with microglia for 1 week, hPSC-derived astrocytes exhibited more complex morphological features characterized primarily by increased branch length (Figure 2B–D).”
§ A human pluripotent stem cell tri-culture platform to elucidate microglial regulation of retinal ganglion cells in neuroinflammation > RESULTS > Establishment of a Tri-culture Model to Investigate Cellular Interactions Between Retinal Ganglion Cells, Astrocytes, and Microglia
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
54 more claims
Create a free account to see all 99 claims and to verify the 54 references still open.
- It may state two separate claims as one. 26
- The quote only partly states this claim. 1
- Probably not a substantial claim. 18
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ A human pluripotent stem cell tri-culture platform to elucidate microglial regulation of retinal ganglion cells in neuroinflammation > RESULTS > Use of the tri-culture model to investigate interactions between RGCs, astrocytes, and microglia under neuroinflammatory conditions
“At 1 week, LPS-treated cultures showed a significant reduction in RGC viability, with fewer MAP2+ RGCs per field of view”
§ A human pluripotent stem cell tri-culture platform to elucidate microglial regulation of retinal ganglion cells in neuroinflammation > RESULTS > Single Cell RNA-seq profiling of RGCs, microglia, and astrocytes to identify transcriptional correlates underlying neuroinflammatory signatures in tri-culture
“This timepoint was selected to capture early degenerative changes prior to significant RGC loss observed at later stages (Figure 6J–N).”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ A human pluripotent stem cell tri-culture platform to elucidate microglial regulation of retinal ganglion cells in neuroinflammation > RESULTS > Stimulating a pro-inflammatory signature in microglia to explore neuroinflammatory phenotypes
“microglia activated with TNFα in isolation and subsequently transferred on transwell inserts to cultures of RGCs”
§ A human pluripotent stem cell tri-culture platform to elucidate microglial regulation of retinal ganglion cells in neuroinflammation > DISCUSSION
“TNFα-activated microglia conditioned medium transferred to RGC cultures was also sufficient to induce pathological RGC neurite phenotypes”
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971
Microglia Function in the Central Nervous System During Health and Neurodegeneration
Colonna, M., & Butovsky, O. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052358 · Cited by 2,894
Conserved cell types with divergent features in human versus mouse cortex
Hodge, R. D., Bakken, T. E., Miller, J. A., Smith, K. A., Barkan, E. R., Graybuck, L. T., Close, J. L., Long, B., Johansen, N., Penn, O., et al. (2019) · Nature · doi:10.1038/s41586-019-1506-7 · Cited by 1,775
Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets
Gao, C., Jiang, J., Tan, Y., & Chen, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01588-0 · Cited by 1,616
Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution
Masuda, T., Sankowski, R., Staszewski, O., Böttcher, C., Amann, L., Sagar, Scheiwe, C., Nessler, S., Kunz, P., van Loo, G., et al. (2019) · Nature · doi:10.1038/s41586-019-0924-x · Cited by 1,310
iPSC-derived human microglia-like cells to study neurological diseases
Abud, E. M., Ramirez, R. N., Martinez, E. S., Healy, L. M., Nguyen, C. H. H., Newman, S. A., Yeromin, A. V., Scarfone, V. M., Marsh, S. E., Fimbres, C., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.03.042 · Cited by 1,154
Microglial Phagocytosis of Live Neurons
Brown, G. C., & Neher, J. J. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3710 · Cited by 853
Neuroinflammation in Alzheimer disease
Heneka, M. T., van der Flier, W. M., Jessen, F., Hoozemanns, J., Thal, D. R., Boche, D., Brosseron, F., Teunissen, C., Zetterberg, H., Jacobs, A. H., et al. (2025) · Nature Reviews Immunology · doi:10.1038/s41577-024-01104-7 · Cited by 638
Microglia-Astrocyte Crosstalk: An Intimate Molecular Conversation
Jha, M. K., Jo, M., Kim, J.-H., & Suk, K. (2019) · The Neuroscientist · doi:10.1177/1073858418783959 · Cited by 579
Young, K., & Morrison, H. (2018) · Journal of Visualized Experiments · doi:10.3791/57648 · Cited by 574
New insights on the role of microglia in synaptic pruning in health and disease
Hong, S., Dissing-Olesen, L., & Stevens, B. (2016) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2015.12.004 · Cited by 557
Microglia during development and aging
Harry, G. J. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.04.013 · Cited by 524
The role of microglia in retinal neurodegeneration: Alzheimer’s disease, parkinson, and glaucoma.
Ramirez, A. I., de Hoz, R., Salobrar-Garcia, E., Salazar, J. J., Rojas, B., Ajoy, D., López-Cuenca, I., Rojas, P., Triviño, A., & Ramírez, J. M. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00214 · Cited by 466
Astrocytes and microglia: In sickness and in health
Vainchtein, I. D., & Molofsky, A. V. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.01.003 · Cited by 450
McQuade, A., Coburn, M., Tu, C. H., Hasselmann, J., Davtyan, H., & Blurton-Jones, M. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0297-x · Cited by 449
Alzheimer’s Patient Microglia Exhibit Enhanced Aging and Unique Transcriptional Activation
Srinivasan, K., Friedman, B. A., Etxeberria, A., Huntley, M. A., van der Brug, M. P., Foreman, O., Paw, J. S., Modrusan, Z., Beach, T. G., Serrano, G. E., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107843 · Cited by 427
Harms, A. S., Cao, S., Rowse, A. L., Thome, A. D., Li, X., Mangieri, L. R., Cron, R. Q., Shacka, J. J., Raman, C., & Standaert, D. G. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5610-12.2013 · Cited by 406
Furukawa, T., Kozak, C. A., & Cepko, C. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3088 · Cited by 354
González, H., Elgueta, D., Montoya, A., & Pacheco, R. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.07.012 · Cited by 352
Early microglia activation in a mouse model of chronic glaucoma
Bosco, A., Steele, M. R., & Vetter, M. L. (2011) · Journal of Comparative Neurology · doi:10.1002/cne.22516 · Cited by 350
Activated microglia in the human glaucomatous optic nerve head
Yuan, L., & Neufeld, A. H. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1104 · Cited by 349
Microglia in the Retina: Roles in Development, Maturity, and Disease
Silverman, S. M., & Wong, W. T. (2018) · Annual Review of Vision Science · doi:10.1146/annurev-vision-091517-034425 · Cited by 346
A single‐cell transcriptome atlas of the adult human retina
Lukowski, S. W., Lo, C. Y., Sharov, A. A., Nguyen, Q., Fang, L., Hung, S. S., Zhu, L., Zhang, T., Grünert, U., Nguyen, T., et al. (2019) · The EMBO Journal · doi:10.15252/embj.2018100811 · Cited by 342
Bosco, A., Inman, D. M., Steele, M. R., Wu, G., Soto, I., Marsh-Armstrong, N., Hubbard, W. C., Calkins, D. J., Horner, P. J., & Vetter, M. L. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-1337 · Cited by 323
The biological function and significance of CD74 in immune diseases
Su, H., Na, N., Zhang, X., & Zhao, Y. (2017) · Inflammation Research · doi:10.1007/s00011-016-0995-1 · Cited by 306
Microglia are the major cell type expressing MHC class II in human white matter
Hayes, G. M., Woodroofe, M. N., & Cuzner, M. L. (1987) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(87)90218-8 · Cited by 302
Directed differentiation of functional astroglial subtypes from human pluripotent stem cells
Krencik, R., & Zhang, S.-C. (2011) · Nature Protocols · doi:10.1038/nprot.2011.405 · Cited by 295
Microglial phagocytosis of neurons in neurodegeneration, and its regulation
Butler, C. A., Popescu, A. S., Kitchener, E. J. A., Allendorf, D. H., Puigdellívol, M., & Brown, G. C. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15327 · Cited by 295
Soto, I., Oglesby, E., Buckingham, B. P., Son, J. L., Roberson, E. D. O., Steele, M. R., Inman, D. M., Vetter, M. L., Horner, P. J., & Marsh-Armstrong, N. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3714-07.2008 · Cited by 274
Guttikonda, S. R., Sikkema, L., Tchieu, J., Saurat, N., Walsh, R. M., Harschnitz, O., Ciceri, G., Sneeboer, M., Mazutis, L., Setty, M., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-020-00796-z · Cited by 243
Neuroinflammation and microglia in glaucoma: time for a paradigm shift
Wei, X., Cho, K., Thee, E. F., Jager, M. J., & Chen, D. F. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24256 · Cited by 236
A comparison of some organizational characteristics of the mouse central retina and the human macula
Volland, S., Esteve-Rudd, J., Hoo, J., Yee, C., & Williams, D. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125631 · Cited by 229
Contribution of Microglia‐Mediated Neuroinflammation to Retinal Degenerative Diseases
Madeira, M. H., Boia, R., Santos, P. F., Ambrósio, A. F., & Santiago, A. R. (2015) · Mediators of Inflammation · doi:10.1155/2015/673090 · Cited by 227
MFG-E8 Mediates Primary Phagocytosis of Viable Neurons during Neuroinflammation
Fricker, M., Neher, J. J., Zhao, J.-W., Théry, C., Tolkovsky, A. M., & Brown, G. C. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.4837-11.2012 · Cited by 218
Connecting the Retina to the Brain
Erskine, L., & Herrera, E. (2014) · ASN Neuro · doi:10.1177/1759091414562107 · Cited by 199
RNA Binding Protein with Multiple Splicing: A New Marker for Retinal Ganglion Cells
Kwong, J. M. K., Caprioli, J., & Piri, N. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.09-4098 · Cited by 191
Luo, C., Yang, X., Kain, A. D., Powell, D. W., Kuehn, M. H., & Tezel, G. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-5407 · Cited by 188
Li, J., Pan, L., Pembroke, W. G., Rexach, J. E., Godoy, M. I., Condro, M. C., Alvarado, A. G., Harteni, M., Chen, Y.-W., Stiles, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24232-3 · Cited by 184
Cell types and cell circuits in human and non-human primate retina
Grünert, U., & Martin, P. R. (2020) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100844 · Cited by 181
Sluch, V. M., Chamling, X., Liu, M. M., Berlinicke, C. A., Cheng, J., Mitchell, K. L., Welsbie, D. S., & Zack, D. J. (2017) · Stem Cells Translational Medicine · doi:10.1002/sctm.17-0059 · Cited by 157
Grimaldi, A., Pediconi, N., Oieni, F., Pizzarelli, R., Rosito, M., Giubettini, M., Santini, T., Limatola, C., Ruocco, G., Ragozzino, D., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00925 · Cited by 157
Regulation of microglia development and homeostasis.
Greter, M., & Merad, M. (2013) · Glia · doi:10.1002/glia.22408 · Cited by 141
Fricker, M., Oliva-Martín, M. J., & Brown, G. C. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-196 · Cited by 137
Early Reduction of Microglia Activation by Irradiation in a Model of Chronic Glaucoma
Bosco, A., Crish, S. D., Steele, M. R., Romero, C. O., Inman, D. M., Horner, P. J., Calkins, D. J., & Vetter, M. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043602 · Cited by 135
Glaucoma: from pathogenic mechanisms to retinal glial cell response to damage
Fernández‐Albarral, J. A., Ramirez, A. I., de Hoz, R., Matamoros, J. A., Salobrar‐García, E., Elvira‐Hurtado, L., López‐Cuenca, I., Sánchez-Puebla, L., Salazar, J. J., & Ramirez, J. M. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1354569 · Cited by 114
Mizee, M. R., Miedema, S. S. M., van der Poel, M., Adelia, Schuurman, K. G., van Strien, M. E., Melief, J., Smolders, J., Hendrickx, D. A., Heutinck, K. M., et al. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0418-8 · Cited by 113
VanderWall, K. B., Huang, K.-C., Pan, Y., Lavekar, S. S., Fligor, C. M., Allsop, A. R., Lentsch, K. A., Dang, P., Zhang, C., Tseng, H. C., et al. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.05.009 · Cited by 108
Self-citationNeurotoxic A1 astrocytes promote neuronal ferroptosis via CXCL10/CXCR3 axis in epilepsy
Liang, P., Zhang, X., Zhang, Y., Wu, Y., Song, Y., Wang, X., Chen, T.-X., Liu, W., Peng, B., Yin, J., et al. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.01.002 · Cited by 103
Gober, R., Ardalan, M., Shiadeh, S. M. J., Duque, L., Garamszegi, S. P., Ascona, M. C., Barreda, A., Sun, X., Mallard, C. E., & Vontell, R. (2021) · Brain Pathology · doi:10.1111/bpa.13003 · Cited by 95
Crair, M. C., & Mason, C. A. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1711-16.2016 · Cited by 88
Retinal-Cell–Conditioned Medium Prevents TNF-α-Induced Apoptosis of Purified Ganglion Cells
Fuchs, C., Forster, V., Balse, E., Sahel, J., Picaud, S. A., & Tessier, L. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.04-1177 · Cited by 83
Molecular signatures of retinal ganglion cells revealed through single cell profiling
Laboissonniere, L. A., Goetz, J. J., Martin, G. M., Bi, R., Lund, T. J. S., Ellson, L., Lynch, M. R., Mooney, B., Wickham, H., Liu, P., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-52215-4 · Cited by 79
Harkin, J., Peña, K. H., Gomes, C., Hernandez, M., Lavekar, S. S., So, K., Lentsch, K., Feder, E. M., Morrow, S., Huang, K.-C., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2317285121 · Cited by 79
Self-citationEmerging Roles of Complement Protein C1q in Neurodegeneration
Cho, K. (2019) · Aging and disease · doi:10.14336/ad.2019.0118 · Cited by 72
The Interaction Between Microglia and Macroglia in Glaucoma
Zhao, X., Sun, R., Luo, X., Wang, F., & Sun, X. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.610788 · Cited by 59
Microglia depletion exacerbates retinal ganglion cell loss in a mouse model of glaucoma
Tan, Z., Guo, Y., Shrestha, M., Sun, D., Gregory-Ksander, M., & Jakobs, T. C. (2022) · Experimental Eye Research · doi:10.1016/j.exer.2022.109273 · Cited by 53
Hornik, T. C., Vilalta, A., & Brown, G. C. (2016) · Journal of Cell Science · doi:10.1242/jcs.174631 · Cited by 47
VanderWall, K. B., Vij, R., Ohlemacher, S. K., Sridhar, A., Fligor, C. M., Feder, E. M., Edler, M. C., Baucum, A. J., Cummins, T. R., & Meyer, J. S. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.12.010 · Cited by 46
Self-citationWang, Y., Chen, S., Wang, J., Liu, Y., Chen, Y., Wen, T., Fang, X., Vidal‐Sanz, M., Jonas, J. B., & Zhang, X. (2021) · Cell Death and Disease · doi:10.1038/s41419-020-03337-5 · Cited by 46
Microglia and Other Myeloid Cells in Central Nervous System Health and Disease
Gopinath, A., Collins, A., Khoshbouei, H., & Streit, W. J. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.265058 · Cited by 44
CNS cell-type localization and LPS response of TLR signaling pathways
McCarthy, G. M., Bridges, C. R., Blednov, Y. A., & Harris, R. A. (2017) · F1000Research · doi:10.12688/f1000research.12036.1 · Cited by 43
Gomes, C., VanderWall, K. B., Pan, Y., Lu, X., Lavekar, S. S., Huang, K.-C., Fligor, C. M., Harkin, J., Zhang, C., Cummins, T. R., et al. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.05.006 · Cited by 42
Self-citationLish, A. M., Ashour, N., Pearse, R. V., Galle, P. C., Orme, G. A., Heuer, S. E., Benoit, C. R., Alexander, K. D., Grogan, E. F. L., Terzioglu, G., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115777 · Cited by 36
Wahlin, K. J., Cheng, J., Jurlina, S. L., Jones, M. K., Dash, N., Ogata, A. R., Kibria, N., Ray, S. S., Eldred, K. C., Kim, C., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.764725 · Cited by 34
Induction of astrocyte reactivity promotes neurodegeneration in human pluripotent stem cell models
Gomes, C., Huang, K.-C., Harkin, J., Baker, A., Hughes, J. M., Pan, Y., Tutrow, K., VanderWall, K. B., Lavekar, S. S., Hernandez, M., et al. (2024) · Stem Cell Reports · doi:10.1016/j.stemcr.2024.07.002 · Cited by 33
Self-citationMicroglia depletion leads to increased susceptibility to ocular hypertension-dependent glaucoma
Diemler, C. A., MacLean, M., Heuer, S. E., Hewes, A. A., Marola, O. J., Libby, R. T., & Howell, G. R. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1396443 · Cited by 28
Isolation of Human CD49f+ Astrocytes and In Vitro iPSC-Based Neurotoxicity Assays
Barbar, L., Rusielewicz, T., Zimmer, M., Kalpana, K., & Fossati, V. (2020) · STAR Protocols · doi:10.1016/j.xpro.2020.100172 · Cited by 24
Microglia: Friends or Foes in Glaucoma? A Developmental Perspective
Ahmad, I., & Subramani, M. (2022) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szac077 · Cited by 23
Agarwal, D., Dash, N., Mazo, K. W., Chopra, M., Avila, M. P., Patel, A., Wong, R. M., Jia, C., Do, H., Cheng, J., et al. (2023) · npj Regenerative Medicine · doi:10.1038/s41536-023-00327-x · Cited by 21
Bian, F., Daghsni, M., Lu, F., Liu, S., Gross, J. M., & Aldiri, I. (2022) · Development · doi:10.1242/dev.200642 · Cited by 19
Atac, D., Maggi, K., Feil, S., Maggi, J., Cuevas, E., Sowden, J. C., Koller, S., & Berger, W. (2024) · Cells · doi:10.3390/cells13131142 · Cited by 11
Harkin, J., Gomes, C., Tutrow, K. D., Afify, R., Patil, S. V., Peña, K. H., Baker, A., Lavekar, S. S., Huang, K.-C., & Meyer, J. S. (2025) · doi:10.1101/2025.07.01.662573 · Cited by 3
Self-citationMicroglia Depletion leads to Increased Susceptibility to Ocular Hypertension-Dependent Glaucoma
Diemler, C. A., MacLean, M., Heuer, S. E., Hewes, A. A., Marola, O. J., Libby, R. T., & Howell, G. R. (2024) · doi:10.1101/2024.03.05.583529 · Cited by 2
Cited by
Generation of xenobiotic free retinofugal assembloids
Hayes, M., Michel, M. F. V., Kuehn, M. H., Kardon, R. H., & Gramlich, O. W. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1746709 · Cited by 3
Salkar, A., Palanivel, V., Basavarajappa, D. K., Heng, B., Schulz, A. M., Gupta, V. K., Graham, S. L., Mirzaei, M., & You, Y. (2026) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-01905 · Cited by 2
Neuroinflammation in glaucoma: a myriad of cellular pathways and players
MacLean, M., Lydon, S. D., Gomes, C., Pizzi, E. M., Diemler, C. A., Yablonski, S. E. R., Howell, G. R., Meyer, J. S., & Libby, R. T. (2026) · Mammalian Genome · doi:10.1007/s00335-026-10253-0 · Cited by 1
Self-citation
Metadata
- Authors
- Harkin, J., Gomes, C., Afify, R., Patil, S. V., Hetzer, S. M., Tutrow, K. D., Peña, K. H., Baker, A., Lavekar, S. S., Huang, K.-C., & Meyer, J. S.
- Affiliations
- Indiana University Indianapolis (US)
- Corresponding author
- Meyer, Jason S.
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2026-08-19
- Volume
- 123
- Issue
- 34
- Pages
- e2522958123-e2522958123
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC13506028
- OpenAlex
- W4412024286
- Cited by
- 3
- References
- 72
- Citations by year
- 2026: 3
- FWCI
- 5.12
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion, cc-by-nc-nd)
- bioRxiv (Cold Spring Harbor Laboratory) (submittedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- PubMed (submittedVersion)
- PubMed Central (submittedVersion, cc-by-nc-nd)
- Funders
- HHS | NIH | National Eye Institute (R01EY033022, U24EY033269)
- Gilbert Family Foundation (923016)
- BrightFocus Foundation (G2020369, G2022003F)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Keywords
- retinal ganglion cells, microglia, neuroinflammation, optic neuropathy, glaucoma, human pluripotent stem cells, triculture, astrocytes, lipopolysaccharide, microglial activation, neuroimmune interactions, optic nerve diseases
- MeSH terms
- Neuroinflammatory Diseases, Astrocytes, Humans, Inflammation, Lipopolysaccharides, Retinal Ganglion Cells, Microglia, Coculture Techniques, Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.